Inventor · disambiguated record
Thomas B. Marriott
Also filed as: MARRIOTT III THOMAS B · MARRIOTT THOMAS B
26 granted patents·38 pending applications·262 citations·filing 1980–2021
96Inventor score
Top patents by PatentIndex Score
64 records- 0198US9545434B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2015·Granted Jan 17, 2017·38 cites·23 claims
- 0298US7847061B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2005·Granted Dec 7, 2010·58 cites·18 claims
- 0396US9060992B2Treatment of short bowel syndrome patients with colon-in-continuitySANGUINETTI ELIZABETH LEMAIRE·Filed 2010·Granted Jun 23, 2015·53 cites·26 claims
- 0489US4654370AGlyceryl valproatesABBOTT LAB·Filed 1980·Granted Mar 31, 1987·96 cites·25 claims
- 0587US2020129593A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0684US7235258B1Sustained-release formulations for treating CNS-mediated disordersNPS PHARMA INC·Filed 2000·Granted Jun 26, 2007·17 cites·8 claims
- 0781US2021213105A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0881US2021213106A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0980US2021077586A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1080US2021236603A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1180US2020147181A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1279US2019269760A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1379US2019381146A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1479US2019275111A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1579US2019298807A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1679US2020016241A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1779US2020405818A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1879US2019307852A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1979US2019262427A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2079US2019275112A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2179US2019351027A1Treatment of Short Bowel Syndrome Patients with Colon-in-ContinuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2279US2019275113A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2379US2019298806A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2479US2020390862A1Treatment of Short Bowel Syndrome Patients with Colon-in-ContinuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2579US2021015903A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2679US2019262428A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2778US2021015904A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2878US2020376085A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2978US2020376084A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3078US2021038695A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3178US2021000923A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3277US2020164043A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3377US2020397866A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3477US2020138910A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3577US2020129594A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3677US2020164040A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3776US2018264087A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3876US2020164041A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3976US2020147182A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4076US2020206316A1Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4173US9999656B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted Jun 19, 2018·0 cites·7 claims
- 4273US9993528B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·0 cites·7 claims
- 4373US9987335B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted Jun 5, 2018·0 cites·7 claims
- 4473US9981014B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·0 cites·22 claims
- 4573US9981016B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·0 cites·15 claims
- 4673US9981015B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·0 cites·7 claims
- 4773US9974836B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted May 22, 2018·0 cites·15 claims
- 4873US9974837B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted May 22, 2018·0 cites·15 claims
- 4973US9974835B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted May 22, 2018·0 cites·15 claims
- 5073US9974838B2Treatment of short bowel syndrome patients with colon-in-continuitySHIRE NPS PHARMACEUTICALS INC·Filed 2016·Granted May 22, 2018·0 cites·7 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas B. Marriott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →